Item 7.01 Regulation FD Disclosure.

On January 21, 2020, Elanco Animal Health Incorporated ("Elanco") announced that it intends to offer for sale to the public 19,159,866 shares of its common stock and 11,000,000 tangible equity units ("Units"). Each Unit has a stated amount of $50 and is composed of (i) a prepaid stock purchase contract and (ii) a senior amortizing note due February 1, 2023, each issued by Elanco. Elanco intends to grant the underwriters in the common stock offering an option to purchase up to an additional 1,915,987 shares of common stock at the public offering price less the underwriting discounts and commissions. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in Items 7.01 and 9.01 of this report (including Exhibit 99.1 hereto) is being "furnished" and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits



Exhibit
No.                                      Description
  99.1       Press release issued by Elanco Animal Health Incorporated, dated
           January 21, 2020.
104.1      Cover Page Interactive Data File (embedded within the Inline XBRL
           document).

© Edgar Online, source Glimpses